Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can ameliorate pathology in a broad range of liver autoimmunity models without impairing host defenses, suggesting organ-wide tolerization.
Guardado en:
Autores principales: | Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d597958e29974428be28085b0fd4c0ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules
por: Pau Serra, et al.
Publicado: (2019) -
Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.
por: Gerd Meyer zu Hörste, et al.
Publicado: (2011) -
Associations of GWAS-Supported Non-MHC Genes with Autoimmune Thyroiditis in Patients with Type 1 Diabetes
por: Liang J, et al.
Publicado: (2021) -
Recent Progress in Rice Broad-Spectrum Disease Resistance
por: Zhiquan Liu, et al.
Publicado: (2021) -
A broad-spectrum bactericidal lipopeptide with anti-biofilm properties
por: Ohad Meir, et al.
Publicado: (2017)